tiprankstipranks
Advertisement
Advertisement
Shandong Boan Boosts 2025 Revenue as Commercial Push Lifts Costs
PremiumCompany AnnouncementsShandong Boan Boosts 2025 Revenue as Commercial Push Lifts Costs
2M ago
Shandong Boan Biotech Sets March 2026 Board Meeting to Approve 2025 Results and Consider Dividend
Premium
Company Announcements
Shandong Boan Biotech Sets March 2026 Board Meeting to Approve 2025 Results and Consider Dividend
2M ago
Shandong Boan Biotechnology’s Controlling Shareholder to Complete H-Share Transfer
Premium
Company Announcements
Shandong Boan Biotechnology’s Controlling Shareholder to Complete H-Share Transfer
4M ago
Shandong Boan’s Denosumab Injections Gain UK Regulatory Acceptance
PremiumCompany AnnouncementsShandong Boan’s Denosumab Injections Gain UK Regulatory Acceptance
7M ago
Shandong Boan Completes Phase III Trial Enrollment for Nivolumab Biosimilar in China
Premium
Company Announcements
Shandong Boan Completes Phase III Trial Enrollment for Nivolumab Biosimilar in China
7M ago
Shandong Boan Biotechnology Proposes Amendments to Articles of Association
Premium
Company Announcements
Shandong Boan Biotechnology Proposes Amendments to Articles of Association
8M ago
Shandong Boan Biotechnology Announces Share Placement
PremiumCompany AnnouncementsShandong Boan Biotechnology Announces Share Placement
10M ago
Shandong Boan Biotechnology Proposes Amendments to Articles of Association Following Share Placement
Premium
Company Announcements
Shandong Boan Biotechnology Proposes Amendments to Articles of Association Following Share Placement
11M ago
Shandong Boan Biotech Gains FDA Approval for BA1302 Clinical Trials
Premium
Company Announcements
Shandong Boan Biotech Gains FDA Approval for BA1302 Clinical Trials
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100